APR 20, 2018 9:29 AM PDT

Programming T Cells To Have Memory and Live for Decades

WRITTEN BY: Kara Marker

Memory T cells: where do they come from and how is their production controlled? Researchers from the Scripps Research Institute believe they have the answer, one which they hope to apply to improved treatment of chronic infections and cancer as well as enhancing the immune response to vaccines.

Scanning electron micrograph of a human T lymphocyte. Credit: NIAID

The key discovery was a transcription factor, a protein called Runx3 that facilitates the transition of T cells into memory T cells. This is opposed to the T cells becoming effector cells, which do not live past the resolution of the infection. Memory T cells can live for many years.

Understanding and manipulating this process could help scientists develop drugs that boost the immune response to vaccines. In other cases of chronic disease, T cells need a boost to continue fighting a prolonged attack on the body, and Runx3 could be the perfect tool to get the job done.

"There are instances such as chronic infection and tumors where the T cells differentiate in an aberrant way that shortens their life span and decreases their function," explained Matthew Pipkin, PhD. "Because our study found that Runx3 is one of the earliest players during an immune response, manipulating it might be an avenue to basically turn back the clock and reprogram dysfunctional T cells into a format that is conducive to them developing into genuine memory cells that are protective.

Pipkin and his team tinkered with Rnx3 expression to see what would happen in the cell, first suppressing it. Any cells lost would be a direct result of lacking Rnx3. So when memory T cell levels dwindled in the absence of Rnx3, researchers could confirm the relationship between the two entities. Additionally, cells with increased expression of Rnx3 produce more memory T cells.

Interestingly, these Rnx3-boosted cells were also more efficient at producing more and more memory T cells when chronically exposed to a virus - lymphocytic choriomeningitis virus (LCMV) - and bacteria - Listeria monocytogenes (compared to cells with a normal amount of Rnx3).

How does it work? Researchers observed that Runx3 suppresses another transcription factor to reduce the number of effector T cells produced, instead pushing cells to become memory T cells. Additionally, Runx3 jumps into action to do so as soon as a few hours after the initial infection.

"We know that Runx3 is working with a number of additional transcription factors and chromatin regulatory proteins," Pipkin says. "So, we are currently trying to identify them and determine how they collaborate with Runx3 to turn on and off different regions of the genome to promote memory development."

The present study was published in the journal Immunity.

Sources: Scripps Research Institute, National Center for Biotechnology Information

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 19, 2020
Infographics
MAR 19, 2020
All You Need to Know About Coronavirus (CoVID-19)
A new coronavirus, first identified in China in December 2019, has caused an outbreak of respiratory illness that was re ...
APR 08, 2020
Immunology
APR 08, 2020
How the Skin Shields Against Zika Infection
Aedes mosquitoes are native of Africa but are commonly found in regions of the Americas, Asia, and the Pacific. These da ...
APR 07, 2020
Microbiology
APR 07, 2020
Second COVID-19 Vaccine Enters Human Trials
Yesterday, Inovio Pharmaceuticals, Inc. announced that it will begin human trials on a potential vaccine for COVID-19.
APR 13, 2020
Immunology
APR 13, 2020
Macrophages: An Origin Story
Macrophages are well-known defense cells of the immune system, responsible for utilizing the cellular breakdown process ...
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
APR 21, 2020
Immunology
APR 21, 2020
A Nasal Vaccine Against Tau Tangles
  One of the hallmarks of Alzheimer’s disease (AD) is the accumulation of “tau tangles”. Tau is a ...
Loading Comments...